BIOCON LTD.
|
Market Cap.(`)
|
36642.31 Cr.
|
P/BV
|
2.05
|
Book Value (`)
|
148.81
|
|
52 Week High/Low ( ` )
|
315/218
|
FV/ML
|
5/1
|
P/E(X)
|
79.20
|
|
Book Closure
|
07/07/2023
|
EPS (`)
|
3.85
|
Div Yield (%)
|
0.49
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 10934.10 | 8184.00 | 6970.10 | 6144.80 | 5381.10 |
| Other Operating Revenues | 240.10 | 0.00 | 135.70 | 155.70 | 133.30 |
| Total Operating Revenues | 11174.20 | 8184.00 | 7105.80 | 6300.50 | 5514.40 |
| | | | | | |
| Other Income | 375.90 | 212.70 | 254.50 | 161.40 | 144.40 |
| Total Revenue | 11550.10 | 8396.70 | 7360.30 | 6461.90 | 5658.80 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 3191.10 | 2813.90 | 2430.20 | 2104.90 | 2029.90 |
| Purchase Of Stock-In Trade | 626.10 | 161.10 | 68.40 | 85.40 | 76.40 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -154.10 | -256.60 | -290.10 | -200.80 | -209.70 |
| Employee Benefit Expenses | 2181.00 | 1880.10 | 1741.00 | 1458.80 | 1165.30 |
| Finance Costs | 419.00 | 67.60 | 57.70 | 64.90 | 70.90 |
| Depreciation And Amortisation Expenses | 1113.10 | 814.20 | 715.10 | 552.20 | 447.80 |
| Other Expenses | 3210.60 | 2091.70 | 1503.70 | 1249.10 | 1328.70 |
| Less: Amounts Transfer To Capital Accounts | 0.00 | 476.40 | 0.00 | 0.00 | 269.90 |
| Less: Share Of Loss From Partnership Firm | 392.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 10194.60 | 7095.60 | 6226.00 | 5314.50 | 4639.40 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1355.50 | 1301.10 | 1134.30 | 1147.40 | 1019.40 |
| | | | | | |
| Exceptional Items | -291.40 | -111.10 | 12.60 | 67.50 | 194.60 |
| Profit/Loss Before Tax | 1064.10 | 1190.00 | 1146.90 | 1214.90 | 1214.00 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 246.20 | 220.40 | 196.60 | 271.30 | 203.80 |
| Less: MAT Credit Entitlement | -98.80 | -23.50 | 25.90 | 37.40 | 13.80 |
| Deferred Tax | -90.90 | -32.40 | 50.80 | 81.20 | 22.30 |
| Total Tax Expenses | 254.10 | 211.50 | 221.50 | 315.10 | 212.30 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 810.00 | 978.50 | 925.40 | 899.80 | 1001.70 |
| | | | | | |
| Profit/Loss From Continuing Operations | 810.00 | 978.50 | 925.40 | 899.80 | 1001.70 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | -9.70 | -28.90 | 0.00 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | -9.70 | -28.90 | 0.00 |
| Profit/Loss For The Period | 810.00 | 978.50 | 915.70 | 870.90 | 1001.70 |
| | | | | | |
| Minority Interest | -180.30 | -123.20 | -105.70 | -122.70 | -97.30 |
| Share Of Profit/Loss Of Associates | -167.00 | -206.90 | -69.50 | 0.00 | 0.90 |
| Consolidated Profit/Loss After MI And Associates | 462.70 | 648.40 | 740.50 | 748.20 | 905.30 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 3.88 | 5.44 | 6.24 | 6.32 | 7.65 |
| Diluted EPS (Rs.) | 3.87 | 5.42 | 6.19 | 6.30 | 7.60 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 60.00 | 0.00 | 0.00 | 63.00 | 72.20 |